These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 31347405)

  • 1. Investigational drugs for the treatment of cancer cachexia: a focus on phase I and phase II clinical trials.
    Molfino A; Amabile MI; Giorgi A; Monti M; D'Andrea V; Muscaritoli M
    Expert Opin Investig Drugs; 2019 Aug; 28(8):733-740. PubMed ID: 31347405
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase II drugs that are currently in development for the treatment of cachexia.
    Dingemans AM; de Vos-Geelen J; Langen R; Schols AM
    Expert Opin Investig Drugs; 2014 Dec; 23(12):1655-69. PubMed ID: 25056249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New developments in investigational HDAC inhibitors for the potential multimodal treatment of cachexia.
    Penna F; Costelli P
    Expert Opin Investig Drugs; 2019 Feb; 28(2):179-189. PubMed ID: 30526137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in pharmacologic strategies for cancer cachexia.
    Madeddu C; Mantovani G; Gramignano G; Macciò A
    Expert Opin Pharmacother; 2015; 16(14):2163-77. PubMed ID: 26330024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel investigational drugs mimicking exercise for the treatment of cachexia.
    Penna F; Pin F; Ballarò R; Baccino FM; Costelli P
    Expert Opin Investig Drugs; 2016; 25(1):63-72. PubMed ID: 26560328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study Design and Rationale for the Phase 3 Clinical Development Program of Enobosarm, a Selective Androgen Receptor Modulator, for the Prevention and Treatment of Muscle Wasting in Cancer Patients (POWER Trials).
    Crawford J; Prado CM; Johnston MA; Gralla RJ; Taylor RP; Hancock ML; Dalton JT
    Curr Oncol Rep; 2016 Jun; 18(6):37. PubMed ID: 27138015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of cachexia: an overview of recent developments.
    von Haehling S; Anker SD
    J Am Med Dir Assoc; 2014 Dec; 15(12):866-72. PubMed ID: 25455531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel treatments for cancer cachexia.
    Bossola M; Pacelli F; Doglietto GB
    Expert Opin Investig Drugs; 2007 Aug; 16(8):1241-53. PubMed ID: 17685872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel investigational biologics for the treatment of cancer cachexia.
    Ma JD; Heavey SF; Revta C; Roeland EJ
    Expert Opin Biol Ther; 2014 Aug; 14(8):1113-20. PubMed ID: 24707881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potential of ghrelin in the treatment of cancer cachexia.
    Argilés JM; Stemmler B
    Expert Opin Biol Ther; 2013 Jan; 13(1):67-76. PubMed ID: 23078025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enobosarm (GTx-024, S-22): a potential treatment for cachexia.
    Srinath R; Dobs A
    Future Oncol; 2014 Feb; 10(2):187-94. PubMed ID: 24490605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anamorelin for patients with cancer cachexia: an integrated analysis of two phase 2, randomised, placebo-controlled, double-blind trials.
    Garcia JM; Boccia RV; Graham CD; Yan Y; Duus EM; Allen S; Friend J
    Lancet Oncol; 2015 Jan; 16(1):108-16. PubMed ID: 25524795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical results in cachexia therapeutics.
    Crawford J
    Curr Opin Clin Nutr Metab Care; 2016 May; 19(3):199-204. PubMed ID: 26974316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multitargeted treatment of cancer cachexia.
    Madeddu C; Maccio A; Mantovani G
    Crit Rev Oncog; 2012; 17(3):305-14. PubMed ID: 22831161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An update on promising agents for the treatment of cancer cachexia.
    Madeddu C; Mantovani G
    Curr Opin Support Palliat Care; 2009 Dec; 3(4):258-62. PubMed ID: 19667995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer cachexia pathophysiology and translational aspect of herbal medicine.
    Suzuki H; Asakawa A; Amitani H; Fujitsuka N; Nakamura N; Inui A
    Jpn J Clin Oncol; 2013 Jul; 43(7):695-705. PubMed ID: 23737606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Editorial update on emerging drugs for cancer cachexia.
    Murphy KT; Lynch GS
    Expert Opin Emerg Drugs; 2012 Mar; 17(1):5-9. PubMed ID: 22229463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Recent development in research and management of cancer anorexia-cachexia syndrome].
    Inui A
    Gan To Kagaku Ryoho; 2005 Jun; 32(6):743-9. PubMed ID: 15984510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anamorelin hydrochloride for the treatment of cancer-anorexia-cachexia in NSCLC.
    Zhang H; Garcia JM
    Expert Opin Pharmacother; 2015 Jun; 16(8):1245-53. PubMed ID: 25945893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer cachexia: it's time for more clinical trials.
    Bossola M; Pacelli F; Tortorelli A; Doglietto GB
    Ann Surg Oncol; 2007 Feb; 14(2):276-85. PubMed ID: 17094025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.